Search details
1.
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
; 72(2): 381-391, 2023 02.
Article
in English
| MEDLINE | ID: mdl-35788059
2.
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Cochrane Database Syst Rev
; 7: CD011585, 2023 07 19.
Article
in English
| MEDLINE | ID: mdl-37467180
3.
Predicted estimates of resting energy expenditure have limited clinical utility in patients with cirrhosis.
J Hepatol
; 77(1): 98-107, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35090958
4.
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.
J Hepatol
; 76(2): 275-282, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34656649
5.
SLC19A1 Genetic Variation Leads to Altered Thiamine Diphosphate Transport: Implications for the Risk of Developing Wernicke-Korsakoff's Syndrome.
Alcohol Alcohol
; 57(5): 581-588, 2022 Sep 10.
Article
in English
| MEDLINE | ID: mdl-35952336
6.
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
Gastroenterology
; 159(4): 1276-1289.e7, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32561361
7.
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers.
Hepatology
; 72(1): 88-102, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31630428
8.
Khat chewing increases the risk for developing chronic liver disease: A hospital-based case-control study.
Hepatology
; 68(1): 248-257, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29369368
9.
Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Cochrane Database Syst Rev
; 6: CD012334, 2019 06 17.
Article
in English
| MEDLINE | ID: mdl-31204790
10.
Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
Cochrane Database Syst Rev
; 6: CD012673, 2019 Jun 20.
Article
in English
| MEDLINE | ID: mdl-31220333
11.
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis.
Am J Gastroenterol
; 113(7): 1099, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29895985
12.
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Am J Gastroenterol
; 113(10): 1475-1483, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29535416
13.
Unexplained chronic liver disease in Ethiopia: a cross-sectional study.
BMC Gastroenterol
; 18(1): 27, 2018 Feb 13.
Article
in English
| MEDLINE | ID: mdl-29439653
14.
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Cochrane Database Syst Rev
; 10: CD011510, 2018 Oct 29.
Article
in English
| MEDLINE | ID: mdl-30372514
15.
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Cochrane Database Syst Rev
; 5: CD012410, 2018 May 15.
Article
in English
| MEDLINE | ID: mdl-29762873
16.
The genetics of alcohol dependence and alcohol-related liver disease.
J Hepatol
; 66(1): 195-211, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27575312
17.
Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
J Hepatol
; 67(1): 120-127, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28161471
18.
Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275-282].
J Hepatol
; 76(5): 1244-1245, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35287983
19.
Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis.
Hepatology
; 64(3): 908-22, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27081787
20.
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.
Cochrane Database Syst Rev
; 8: CD002798, 2017 08 10.
Article
in English
| MEDLINE | ID: mdl-28796283